MENU
+Compare
VRNA
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$58.09
Change
-$2.20 (-3.65%)
Capitalization
5.13B

VRNA Verona Pharma plc Forecast, Technical & Fundamental Analysis

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs... Show more

VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VRNA with price predictions
Apr 02, 2025

VRNA's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for VRNA moved out of overbought territory on March 03, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 instances where the indicator moved out of the overbought zone. In of the 33 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VRNA as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VRNA turned negative on March 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

VRNA moved below its 50-day moving average on April 01, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VRNA entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where VRNA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VRNA advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

VRNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VRNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.096) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (112.360) is also within normal values, averaging (252.036).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VRNA is expected to report earnings to rise 33.40% to -6 cents per share on April 30

Verona Pharma plc VRNA Stock Earnings Reports
Q1'25
Est.
$-0.07
Q4'24
Beat
by $0.02
Q3'24
Est.
$-0.07
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.01
The last earnings report on February 27 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 1.67M shares outstanding, the current market capitalization sits at 5.13B.
A.I. Advisor
published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NFRA58.040.03
+0.05%
FlexShares STOXX Global Broad Infras ETF
BUI22.72-0.02
-0.07%
BlackRock Utilities Infrastructure & Power Opportunities Trust
EAOM27.22-0.32
-1.17%
iShares ESG Aware 40/60 Mod Allc ETF
GREK47.32-0.78
-1.62%
Global X MSCI Greece ETF
AUGZ36.42-1.22
-3.25%
TrueShares Structured Outcome August ETF

VRNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VRNA has been loosely correlated with VCYT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VRNA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRNA
1D Price
Change %
VRNA100%
-3.73%
VCYT - VRNA
38%
Loosely correlated
-5.51%
TRDA - VRNA
34%
Loosely correlated
-9.09%
ATXS - VRNA
33%
Poorly correlated
-6.61%
COGT - VRNA
32%
Poorly correlated
-6.73%
CLDX - VRNA
32%
Poorly correlated
-1.21%
More